Elicio Therapeutics Financial Overview
Elicio Therapeutics's market cap is currently $137.64M. The company's EPS TTM is $-0.6; its P/E ratio is -2.35; Elicio Therapeutics is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.45. See an overview of income statement, balance sheet, and cash flow financials.
